1 |
Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab, 94, 26-34
DOI
|
2 |
Bilinski K, Boyages J (2013) Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study. Breast Cancer Res Treat, 137, 599-607
DOI
ScienceOn
|
3 |
Carlberg C (2003) Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res, 164, 29-42
DOI
|
4 |
Crew KD, Gammon MD, Steck SE, et al (2009) Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res, 2, 598-604
DOI
|
5 |
Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol, 27, 3757-63
DOI
|
6 |
Hatse S, Lambrechts D, Verstuyf A, et al (2012) Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome and genetic determinants of vitamin D insufficiency. Carcinogenesis, 33, 1319-26
DOI
ScienceOn
|
7 |
Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr, 77, 204-10
|
8 |
Holick MF (2006) Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol, 92, 49-59
DOI
|
9 |
Holick MF (2007) Vitamin D deficiency. N Engl J Med, 357, 266-81
DOI
|
10 |
Holick MF (2009) Vitamin D status: measurement, interpretation and clinical application. Ann Epidemiol, 19, 73-8
DOI
|
11 |
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al (2011) Evaluation, treatment and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 96, 1911-30
DOI
ScienceOn
|
12 |
Institute of Medicine (2010) Dietary Reference Intakes for Calcium and Vitamin D. The National Academies Press, Washington
|
13 |
Iqbal SJ (1994) Vitamin D metabolism and the clinical aspects of measuring metabolites. Ann Clin Bio chem, 31, 109-24
DOI
|
14 |
Jacobs ET, Alberts DS, Foote JA, et al (2008) Vitamin D insufficiency in southern Arizona. Am J Clin Nutr, 87, 608-13
|
15 |
Kermani IA, Kojidi HT, Gharamaleki JV, et al (2011) Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer. Asian Pac J Cancer Prev, 12, 1381-4
|
16 |
Kim ML, Il Kang M, Won Oh K, et al (2010) The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol, 73, 330-8
DOI
|
17 |
Kim HJ, Lee YM, Ko BS, et al (2011) Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann Surg Oncol, 18, 1830-6
DOI
|
18 |
Kim HJ, Koh BS, Yu JH, et al (2014) Changes in serum hydroxyvitamin D levels of breast cancer patients during tamoxifen treatment or chemotherapy in premenopausal breast cancer patients. Eur J Cancer, 50, 1403-11
DOI
|
19 |
Lee ES, Ahn J, Patk HM (2009) Serum vitamin D status of Korean postmenopausal women during the winter months. Asia Pac J ClinNutr, 18, 29-33
|
20 |
Manson JE, Mayne ST, Clinton SK (2011) Vitamin D and prevention of cancer-ready for prime time? N Engl J Med, 364, 1385-7
DOI
|
21 |
McCullough ML, Weinstein SJ, Freedman DM, et al (2010) Correlates of circulating 25-hydroxyvitamin D: cohort consortium vitamin d pooling project of rarer cancers. AM J Epidemiol, 172, 21-35
DOI
|
22 |
Mousavi-Jarrrahi SH, Kasaeian A, Mansori K, et al (2013) Addressing the younger age at onset in breast cancer patients in Asia: an age-period-cohort analysis of fifty years of quality data from the international agency for research on cancer. ISRN Oncol, 2013, 429862
|
23 |
Palmieri C, MacGregor T, Girgis S, Vigushin D (2006) Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol, 59, 1334-6
DOI
|
24 |
Peppone LJ, Huston AJ, Reid ME, et al (2011) The effect of various vitamin D supplementation regimens in breast cancer patients. Breast Cancer Res Treat, 127, 171-7
DOI
|
25 |
Shi L, Nechuta S, Gao YT, et al (2014) Correlates of 25-hydroxyvitamin D among Chinese breast cancer patients. PLoS One, 9, 86467
DOI
|
26 |
Vance V, Campbell S, McCargar L, Mourtzakis M, Hanning R (2014) Dietary changes and food intake in the first year after breast cancer treatment. Appl Physiol Nutr Metab, 39, 707-14
DOI
|
27 |
Villasenor A, Ballard-Barbash R, Ambs A, et al (2013) Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control, 24, 759-67
DOI
|
28 |
Alipour S, HadjiM, Hosseini L, et al (2014) Levels of serum 25-hydroxy-vitamin D in benign and malignant breast masses. Asian Pac J Cancer Prev, 15, 129-32
DOI
|